LakeShore Biopharma Co., Ltd (LSB) — Net Asset Momentum
LakeShore Biopharma Co., Ltd (LSB) recorded a net asset momentum of -14.6% as of March 2025, with net assets of $499.75 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of LakeShore Biopharma Co., Ltd to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
LakeShore Biopharma Co., Ltd Net Asset Momentum (2021–2025)
This chart tracks LakeShore Biopharma Co., Ltd's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -14.6%, with net assets of $499.75 Million USD as of March 2025. Read how much debt does LakeShore Biopharma Co., Ltd carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for LakeShore Biopharma Co., Ltd (2021–2025)
The table below shows the complete annual net asset history for LakeShore Biopharma Co., Ltd from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of LakeShore Biopharma Co., Ltd.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $499.75 Million | $1.37 Billion | $867.91 Million | ▼ -14.6% |
| 2024 | $585.21 Million | $1.51 Billion | $927.82 Million | ▼ -19.7% |
| 2023 | $728.45 Million | $1.72 Billion | $991.30 Million | ▲ +303.2% |
| 2022 | $180.68 Million | $201.03 Million | $20.35 Million | ▲ +845631.8% |
| 2021 | $21.36K | $91.37K | $70.01K | — |